36.01

0.45% 0.16

Harmony Biosciences Holdings Inc (HRMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRMY Giù? Forum Previsione

Precedente Chiudi:

$35.85

Aprire:

$36.4

Volume 24 ore:

476.25K

Relative Volume:

0.72

Capitalizzazione di mercato:

$2.07B

Reddito:

$772.53M

Utile/perdita netta:

$180.90M

Rapporto P/E:

11.61

EPS:

3.1024

Flusso di cassa netto:

$258.73M

1 W Prestazione:

-3.38%

1M Prestazione:

+0.70%

6M Prestazione:

-1.80%

1 anno Prestazione:

-7.84%

Intervallo 1D:

$35.97

$36.95

Intervallo di 1 settimana:

$35.57

$38.21

Portata 52W:

$25.52

$40.87

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Nome

Harmony Biosciences Holdings Inc

Settore

Healthcare (1111)

Industria

Biotechnology (622)

Telefono

(484) 539-9800

Indirizzo

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Dipendente

268

Cinguettio

Prossima data di guadagno

2024-10-29

Ultimi documenti SEC

HRMY's Discussions on Twitter

Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRMY Harmony Biosciences Holdings Inc	36.01	2.06B	772.53M	180.90M	258.73M	3.1024
VRTX Vertex Pharmaceuticals Inc	491.47	117.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	803.17	82.85B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	821.96	51.58B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	314.40	40.75B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.07	38.33B	4.98B	69.60M	525.67M	0.5198

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-11	Ripresa	UBS	Neutral
2025-07-21	Iniziato	Truist	Buy
2025-07-10	Ripresa	Goldman	Neutral
2025-06-02	Ripresa	Oppenheimer	Outperform
2025-02-11	Iniziato	Deutsche Bank	Buy
2024-12-17	Iniziato	H.C. Wainwright	Buy
2024-10-10	Ripresa	Raymond James	Outperform
2024-09-10	Iniziato	UBS	Buy
2024-06-21	Iniziato	Citigroup	Buy
2024-01-02	Downgrade	BofA Securities	Neutral → Underperform
2023-09-25	Downgrade	Goldman	Neutral → Sell
2023-09-07	Iniziato	Berenberg	Buy
2023-04-20	Iniziato	BofA Securities	Neutral
2022-10-14	Aggiornamento	Janney	Neutral → Buy
2022-10-14	Aggiornamento	Jefferies	Hold → Buy
2022-08-03	Downgrade	Jefferies	Buy → Hold
2022-07-13	Downgrade	Goldman	Buy → Neutral
2022-07-07	Iniziato	Mizuho	Buy
2022-04-14	Iniziato	Cantor Fitzgerald	Overweight
2021-12-01	Iniziato	Oppenheimer	Outperform
2021-11-04	Iniziato	Raymond James	Outperform
2021-09-23	Iniziato	Needham	Buy
2021-03-29	Aggiornamento	Goldman	Neutral → Buy
2020-09-14	Iniziato	Goldman	Neutral
2020-09-14	Iniziato	Jefferies	Buy
2020-09-14	Iniziato	Piper Sandler	Overweight

Mostra tutto

Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie

05:52 AM

LSV Asset Management Increases Stake in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

05:52 AM

01:56 AM

Understanding Momentum Shifts in (HRMY) - Stock Traders Daily

01:56 AM

Feb 13, 2026

Trend Review: Is Harmony Biosciences Holdings Inc part of any ETFWeekly Stock Report & Community Consensus Trade Alerts - baoquankhu1.vn

Feb 13, 2026

MACD Signal: Is Harmony Biosciences Holdings Inc impacted by rising ratesJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn

Feb 13, 2026

Feb 12, 2026

Can Harmony Biosciences Holdings Inc. stock attract ESG capital inflowsJuly 2025 Earnings & Weekly High Potential Alerts - mfd.ru

Feb 12, 2026

Wall Street Analysts Believe Harmony Biosciences (HRMY) Could Rally 26.95%: Here's is How to Trade - Finviz

Feb 12, 2026

Assessing Harmony Biosciences (HRMY) Valuation As Analyst Optimism And Earnings Anticipation Grow - Yahoo Finance

Feb 12, 2026

Feb 11, 2026

Harmony Biosciences (NASDAQ:HRMY) Receives "Neutral" Rating from UBS Group - MarketBeat

Feb 11, 2026